Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total reven
PUK
BABA, FBIN, LAZ, PTON, SMCI, K, SNAP, AAP, VFC, CAVA, IART, GEV, RKT, MRNA, PLTR
JNJ
PUK
PBR, CVX, TTE, NVO, PUK, NKE, BP, EQNR, XOM, TTFNF, REPYY, SHEL, GE, ZHHJY
Debbie S. Wang
Senior Equity Analyst